{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:08:48Z","timestamp":1784156928410,"version":"3.55.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.tube.2024.102522","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T16:15:07Z","timestamp":1717172107000},"page":"102522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview"],"prefix":"10.1016","volume":"148","author":[{"given":"Andrea","family":"Sanchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Lanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-512X","authenticated-orcid":false,"given":"Federico","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mustazzolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2024.102522_bib1","series-title":"Medical Microbiology. Ninth","author":"Murray","year":"2020"},{"key":"10.1016\/j.tube.2024.102522_bib2","series-title":"Global tuberculosis report","year":"2023"},{"key":"10.1016\/j.tube.2024.102522_bib3","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new End TB Strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2024.102522_bib4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS (Fed Eur Microbiol Soc) Microbiol Rev"},{"key":"10.1016\/j.tube.2024.102522_bib5","series-title":"WHO consolidated guidelines","year":"2022"},{"key":"10.1016\/j.tube.2024.102522_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00959-2021","article-title":"Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?","volume":"58","author":"Alagna","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102522_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00361-2021","article-title":"New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization","volume":"57","author":"Viney","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102522_bib8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jmoldx.2022.07.005","article-title":"Diagnostic capacities for multidrug-resistant tuberculosis in the World Health organization European region action is needed by all member States","volume":"24","author":"Maurer","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.tube.2024.102522_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3201\/eid2703.204418","article-title":"Limited capability for testing Mycobacterium tuberculosis for susceptibility to new drugs","volume":"27","author":"Farooq","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib10","first-page":"m216","article-title":"Current and future treatments for tuberculosis","volume":"368","author":"Lee","year":"2020","journal-title":"BMJ (Clinical Research Ed)"},{"key":"10.1016\/j.tube.2024.102522_bib11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","article-title":"Antibiotic resistance mechanisms in M. tuberculosis: an update","volume":"90","author":"Nguyen","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.tube.2024.102522_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cmi.2016.10.014","article-title":"Whole genome sequencing for M\/XDR tuberculosis surveillance and for resistance testing","volume":"23","author":"Walker","year":"2017","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.tube.2024.102522_bib13","doi-asserted-by":"crossref","first-page":"E320","DOI":"10.1016\/S2666-5247(21)00044-6","article-title":"Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study","volume":"2","author":"Zurcher","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.tube.2024.102522_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/thoraxjnl-2019-214004","article-title":"Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling","volume":"76","author":"Mugwagwa","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.tube.2024.102522_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/diagnostics12010208","article-title":"Recent developments in phenotypic and molecular diagnostic methods for antimicrobial resistance detection in Staphylococcus aureus: a narrative review","volume":"12","author":"Sanchini","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.tube.2024.102522_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1179\/2047480615Z.000000000329","article-title":"Writing narrative style literature reviews","volume":"24","author":"Ferrari","year":"2015","journal-title":"Med Writ"},{"key":"10.1016\/j.tube.2024.102522_bib17","article-title":"Resistance Sniffer: an online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data","volume":"310","author":"Muzondiwa","year":"2020","journal-title":"Inter J Med Microbio : IJMM"},{"key":"10.1016\/j.tube.2024.102522_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijmyco.2013.09.001","article-title":"Evaluation of the effectiveness of BACTEC MGIT 960 for the detection of mycobacteria in Bangladesh","volume":"2","author":"Hasan","year":"2013","journal-title":"Inter J Mycobacteriology"},{"key":"10.1016\/j.tube.2024.102522_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/ers.09.45","article-title":"Drug-susceptibility testing in TB: current status and future prospects","volume":"3","author":"Richter","year":"2009","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.tube.2024.102522_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj4124","article-title":"Point-of-care diagnostic tests for tuberculosis disease","volume":"14","author":"Hong","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2024.102522_bib21","first-page":"288.e1","volume":"vol. 27","author":"Sch\u00f6n","year":"2021"},{"key":"10.1016\/j.tube.2024.102522_bib22","series-title":"Handbook on tuberculosis laboratory diagnostic methods in the European Union: updated 2018","year":"2018"},{"key":"10.1016\/j.tube.2024.102522_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.754249","article-title":"Primary bedaquiline resistance among cases of drug-resistant tuberculosis in Taiwan","volume":"12","author":"Wu","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jiph.2023.11.018","article-title":"The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: observations on surveillance data","volume":"17","author":"Li","year":"2024","journal-title":"J Infection Public Health"},{"key":"10.1016\/j.tube.2024.102522_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12020410","article-title":"Performance of WHO-endorsed rapid tests for detection of susceptibility to first-line drugs in patients with pulmonary tuberculosis in Bangladesh","volume":"12","author":"Rahman","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.tube.2024.102522_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00344-18","article-title":"Validating a 14-drug microtiter plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis","volume":"62","author":"Rancoita","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.01209-13","article-title":"Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs","volume":"58","author":"Lee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib28","article-title":"Molecular determinants of Ethionamide resistance in clinical isolates of Mycobacterium tuberculosis","volume":"11","author":"Ushtanit","year":"2022","journal-title":"Antibiotics-Basel"},{"key":"10.1016\/j.tube.2024.102522_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00322-22","article-title":"Variants in bedaquiline-candidate-resistance genes: prevalence in bedaquiline-naive patients, effect on MIC, and association with Mycobacterium tuberculosis lineage","volume":"66","author":"Rivi\u00e8re","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib30","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.2147\/IDR.S440711","article-title":"Bedaquiline, delamanid, linezolid, clofazimine, and Capreomycin MIC distributions for drug resistance Mycobacterium tuberculosis in Shanghai, China","volume":"16","author":"Guo","year":"2023","journal-title":"IDR"},{"key":"10.1016\/j.tube.2024.102522_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105108","article-title":"Crystal violet decolorization assay: a simplified colorimetric test for the rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates","author":"Reghunath","year":"2023","journal-title":"Microb Infect"},{"key":"10.1016\/j.tube.2024.102522_bib32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/ijmy.ijmy_42_20","article-title":"Colorimetric methods for rapid determination of pyrazinamide resistance","volume":"9","author":"Akbal","year":"2020","journal-title":"Inter J Mycobacteriology"},{"key":"10.1016\/j.tube.2024.102522_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-023-00568-0","article-title":"Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China","volume":"22","author":"Hu","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.tube.2024.102522_bib34","first-page":"138","article-title":"Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection","volume":"3","author":"Mejia","year":"1999","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.tube.2024.102522_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02263-20","article-title":"Thin-layer-agar-based direct phenotypic drug susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance otherwise missed by WHO-endorsed diagnostic tests","volume":"65","author":"Ardizzoni","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib36","first-page":"213","article-title":"MDR\/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia","volume":"90","author":"Shibabaw","year":"2020","journal-title":"Int J Infect Dis : IJID : Off Publication International Soc Infectious Dis"},{"key":"10.1016\/j.tube.2024.102522_bib37","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001331","article-title":"The simple direct slide method is comparable to indirect Lowenstein Jensen proportion culture for detecting rifampicin resistant tuberculosis","volume":"70","author":"Achan","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4046\/trd.2021.0134","article-title":"A rapid assessing method of drug susceptibility using flow cytometry for Mycobacterium tuberculosis isolates resistant to isoniazid, rifampin, and ethambutol","volume":"85","author":"Lee","year":"2022","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.tube.2024.102522_bib39","first-page":"S15","article-title":"MDR\/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network","volume":"92S","author":"Migliori","year":"2020","journal-title":"Int J Infect Dis : IJID : Off Publication International Soc Infectious Dis"},{"key":"10.1016\/j.tube.2024.102522_bib40","series-title":"Use of Xpert MTB\/RIF and Xpert MTB\/RIF Ultra on GeneXpert 10-colour instruments","year":"2021"},{"key":"10.1016\/j.tube.2024.102522_bib41","series-title":"The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance","year":"2016"},{"key":"10.1016\/j.tube.2024.102522_bib42","first-page":"CD009593","article-title":"Xpert Ultra versus Xpert MTB\/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis","volume":"2","author":"Zifodya","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tube.2024.102522_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1473-3099(19)30649-8","article-title":"Xpert MTB\/RIF Ultra versus Xpert MTB\/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study","volume":"20","author":"Donovan","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(21)00481-3","article-title":"Xpert MTB\/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin","volume":"22","author":"Mvelase","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02170-20","article-title":"Value of Xpert MTB\/RIF using bronchoalveolar lavage fluid for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis","volume":"59","author":"Liu","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib46","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2666-5247(20)30007-0","article-title":"Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB\/RIF results: a prospective observational study in Rwanda","volume":"1","author":"Ngabonziza","year":"2020","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.tube.2024.102522_bib47","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2147\/IDR.S358301","article-title":"Detection of Mycobacterium tuberculosis rifampicin resistance conferred by borderline rpoB mutations: Xpert MTB\/RIF is superior to phenotypic drug susceptibility testing","volume":"15","author":"Xia","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.tube.2024.102522_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab173","article-title":"Discordance of the repeat GeneXpert MTB\/RIF test for rifampicin resistance detection among patients initiating MDR-TB treatment in Uganda","volume":"8","author":"Ssengooba","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib49","series-title":"GLI model TB diagnostic algorithms","year":"2018"},{"key":"10.1016\/j.tube.2024.102522_bib50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jiph.2023.04.004","article-title":"Analysis of Xpert MTB\/RIF results in retested patients with very low initial bacterial loads: a retrospective study in China","volume":"16","author":"Wang","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.tube.2024.102522_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-020-4871-9","article-title":"Effect of the Xpert MTB\/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib52","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.3346\/jkms.2020.35.e284","article-title":"Impact of molecular drug susceptibility testing on the time to multidrug-resistant tuberculosis treatment initiation","volume":"35","author":"Jeon","year":"2020","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.tube.2024.102522_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115397","article-title":"Analytical performance of the Xpert MTB\/XDR\u00ae assay for tuberculosis and expanded resistance detection","volume":"101","author":"Georghiou","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02314-20","article-title":"Xpert MTB\/XDR: a 10-color reflex assay suitable for point-of-are settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from Mycobacterium tuberculosis-positive sputum","volume":"59","author":"Cao","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02761-22","article-title":"Drug-resistant tuberculosis on the balkan peninsula: determination of drug resistance mechanisms with Xpert MTB\/XDR and whole-genome sequencing analysis","volume":"11","author":"Truden","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2024.102522_bib56","series-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","year":"2021"},{"key":"10.1016\/j.tube.2024.102522_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261442","article-title":"Equivalence of the GeneXpert system and GeneXpert Omni system for tuberculosis and rifampicin resistance detection","volume":"16","author":"Georghiou","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib58","article-title":"GenoType MTBDRplus assay for rapid detection of multidrug resistance in Mycobacterium tuberculosis: a meta-analysis","volume":"11","author":"Bai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib59","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jac\/dkz564","article-title":"Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact","volume":"75","author":"Van Rie","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijid.2020.04.049","article-title":"Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China","volume":"96","author":"Shi","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib61","article-title":"Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: impact on bedside clinical decision making","volume":"20","author":"Mahomed","year":"2020","journal-title":"J Clin Tuberculosis Other Mycobacterial Dis"},{"key":"10.1016\/j.tube.2024.102522_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261329","article-title":"Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh","volume":"16","author":"Rahman","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229419","article-title":"Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: an Indian perspective","volume":"15","author":"Rufai","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijmmb.2022.05.013","article-title":"Agreement between CBNAAT, liquid culture and line probe assay for detection of Mycobacterium tuberculosis and anti-tubercular drug resistance in extrapulmonary samples","volume":"40","author":"Jain","year":"2022","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2022.115856","article-title":"GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory","volume":"105","author":"Pinhata","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12941-021-00463-6","article-title":"Direct detection of resistance to fluoroquinolones\/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India","volume":"20","author":"Singh","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.tube.2024.102522_bib67","doi-asserted-by":"crossref","first-page":"e920","DOI":"10.1093\/cid\/ciac556","article-title":"Non-actionable results, accuracy, and effect of first- and second-line line probe assays for diagnosing drug-resistant tuberculosis, including on smear-negative specimens, in a high-volume laboratory","volume":"76","author":"Pillay","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2022.06.020","article-title":"Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis","volume":"533","author":"Lin","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.tube.2024.102522_bib69","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/cid\/ciz932","article-title":"Multicenter study of the accuracy of the BD MAX multidrug-resistant tuberculosis assay for detection of Mycobacterium tuberculosis complex and mutations associated with resistance to rifampin and isoniazid","volume":"71","author":"Shah","year":"2020","journal-title":"Clin Infect Dis : Off Publication Infectious Dis Soc Am"},{"key":"10.1016\/j.tube.2024.102522_bib70","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/clinchem\/hvaa172","article-title":"Genomic prediction of antimicrobial resistance: ready or not, here it comes","volume":"66","author":"Ransom","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.tube.2024.102522_bib71","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Genomes project. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2024.102522_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00632-20","article-title":"Application of targeted next-generation sequencing assay on a portable sequencing platform for culture-free detection of drug-resistant tuberculosis from clinical samples","volume":"58","author":"Cabibbe","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13073-016-0385-x","article-title":"The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs","volume":"8","author":"Phelan","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.tube.2024.102522_bib74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/1471-2164-15-881","article-title":"KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes","volume":"15","author":"Steiner","year":"2014","journal-title":"BMC Genom"},{"key":"10.1016\/j.tube.2024.102522_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-015-0164-0","article-title":"Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences","volume":"7","author":"Coll","year":"2015","journal-title":"Genome Med"},{"key":"10.1016\/j.tube.2024.102522_bib76","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.tube.2015.09.002","article-title":"CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): a publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates","volume":"95","author":"Iwai","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2024.102522_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10063","article-title":"Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis","volume":"6","author":"Bradley","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2024.102522_bib78","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1128\/JCM.00025-15","article-title":"PhyResSE: a web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data","volume":"53","author":"Feuerriegel","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12864-022-08291-4","article-title":"A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis","volume":"23","author":"Deelder","year":"2022","journal-title":"BMC Genom"},{"key":"10.1016\/j.tube.2024.102522_bib80","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","article-title":"The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis","volume":"3","author":"Walker","year":"2022","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.tube.2024.102522_bib81","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/17843286.2021.1999588","article-title":"Retrospective evaluation of routine whole genome sequencing of Mycobacterium tuberculosis at the Belgian National Reference Center, 2019","volume":"77","author":"Soetaert","year":"2022","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.tube.2024.102522_bib82","article-title":"Mutations in Mycobacterium tuberculosis isolates with discordant results for drug-susceptibility testing in Peru","volume":"2020","author":"Solari","year":"2020","journal-title":"Inter J Microbio"},{"key":"10.1016\/j.tube.2024.102522_bib83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12879-022-07329-y","article-title":"Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance","volume":"22","author":"Park","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2024.102522_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94297-z","article-title":"Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country","volume":"11","author":"Vogel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2024.102522_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00583-20","article-title":"Assessing Nanopore sequencing for clinical diagnostics: a comparison of next-generation sequencing (NGS) methods for Mycobacterium tuberculosis","volume":"59","author":"Smith","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"Suppl","key":"10.1016\/j.tube.2024.102522_bib86","first-page":"S48","article-title":"Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection","volume":"113","author":"Lam","year":"2021","journal-title":"Int J Infect Dis : IJID : Off Publication International Soc Infectious Dis"},{"key":"10.1016\/j.tube.2024.102522_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31236-0","article-title":"A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis","volume":"13","author":"Green","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2024.102522_bib88","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/jac\/dkad252","article-title":"Investigation of genomic mutations and their association with phenotypic resistance to new and repurposed drugs in Mycobacterium tuberculosis complex clinical isolates","volume":"78","author":"Mok","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.775030","article-title":"Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: updates on recent developments in the field","volume":"13","author":"Dookie","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2022.102332","article-title":"Tuberculosis drug resistance profiling based on machine learning: a literature review","volume":"26","author":"Sharma","year":"2022","journal-title":"Braz J Infect Dis : Off Publication Brazilian Soc Infectious Dis"},{"key":"10.1016\/j.tube.2024.102522_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-11287-5","article-title":"Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020","volume":"12","author":"Dohal","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2024.102522_bib92","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/labmed\/lmaa016","article-title":"A rapid and accurate detection approach for multidrug-resistant tuberculosis based on PCR-ELISA microplate hybridization assay","volume":"51","author":"Zhou","year":"2020","journal-title":"Lab Med"},{"key":"10.1016\/j.tube.2024.102522_bib93","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3343\/alm.2020.40.2.142","article-title":"Evaluation of the QuantaMatrix multiplexed assay platform for molecular diagnosis of multidrug- and extensively drug-resistant tuberculosis using clinical strains isolated in Myanmar","volume":"40","author":"Chang","year":"2020","journal-title":"Annals Laboratory Med"},{"key":"10.1016\/j.tube.2024.102522_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.974428","article-title":"Clinical utility of target amplicon sequencing test for rapid diagnosis of drug-resistant Mycobacterium tuberculosis from respiratory specimens","volume":"13","author":"Leung","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib95","article-title":"Evaluation of TBMDR\u00ae and XDRA\u00ae for the detection of multidrug resistant and pre-extensively drug resistant tuberculosis","volume":"27","author":"Cho","year":"2022","journal-title":"J Clin Tuberculosis Other Mycobacterial Dis"},{"key":"10.1016\/j.tube.2024.102522_bib96","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.21037\/jtd-21-913","article-title":"Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis","volume":"13","author":"Sun","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.tube.2024.102522_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02168-20","article-title":"Comparative analytical evaluation of four centralized platforms for the detection of Mycobacterium tuberculosis complex and resistance to rifampicin and isoniazid","volume":"59","author":"de Vos","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib98","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00747-2020","article-title":"Diagnostic accuracy of centralised assays for TB detection and detection of resistance to rifampicin and isoniazid: a systematic review and meta-analysis","volume":"57","author":"Kohli","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102522_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12102307","article-title":"Combined locked nucleic acid probes and high-resolution melting curve analysis for detection of rifampicin-resistant tuberculosis in northern Thailand","volume":"12","author":"Thant","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.tube.2024.102522_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192417068","article-title":"Evaluation study of xMAP TIER assay on a microsphere-based platform for detecting first-line anti-tuberculosis drug resistance","volume":"19","author":"Ou","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.tube.2024.102522_bib101","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00526-2021","article-title":"A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays","volume":"58","author":"Penn-Nicholson","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102522_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.796916","article-title":"A recombinase polymerase amplification-coupled Cas12a mutant-based module for efficient detection of streptomycin-resistant mutations in Mycobacterium tuberculosis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib103","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/s41467-021-22705-z","article-title":"Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections","volume":"12","author":"Moreno-Molina","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2024.102522_bib104","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1128\/JCM.01602-13","article-title":"Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods","volume":"51","author":"Folkvardsen","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib106","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-021-00478-z","article-title":"Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis","volume":"20","author":"Ye","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.tube.2024.102522_bib107","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.01209-09","article-title":"Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results","volume":"47","author":"Van Deun","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib108","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: challenging the gold standard","volume":"51","author":"Van Deun","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib109","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01885-20","article-title":"Low-level rifampin resistance and rpoB mutations in Mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York","volume":"59","author":"Shea","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/dkq519","article-title":"Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis","volume":"66","author":"Siu","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib111","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00812-17","article-title":"The new Xpert MTB\/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.tube.2024.102522_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244829","article-title":"Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M\/XDR-TB","volume":"15","author":"Nonghanphithak","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415752","article-title":"Ultrasensitive detection of multidrug-resistant Mycobacterium tuberculosis using SuperSelective primer-based real-time PCR assays","volume":"23","author":"Narang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tube.2024.102522_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.720436","article-title":"Whole-genome sequencing to identify missed rifampicin and isoniazid resistance among tuberculosis isolates-Chennai, India, 2013-2016","volume":"12","author":"Tamilzhalagan","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib115","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00720-21","article-title":"Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis","volume":"65","author":"Werngren","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib116","series-title":"MGIT procedure manual","author":"Siddiqi","year":"2006"},{"key":"10.1016\/j.tube.2024.102522_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2021.100886","article-title":"Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study","volume":"42","author":"Nasiri","year":"2021","journal-title":"New Microbes and New Infections"},{"key":"10.1016\/j.tube.2024.102522_bib118","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01907-21","article-title":"Comparative performance of genomic methods for the detection of pyrazinamide resistance and heteroresistance in Mycobacterium tuberculosis","volume":"60","author":"Whitfield","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib119","article-title":"Reevaluating rifampicin breakpoint concentrations for Mycobacterium tuberculosis isolates with disputed rpoB mutations and discordant susceptibility phenotypes","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2024.102522_bib120","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1021\/acs.analchem.2c00723","article-title":"Fluorescence biosensor for one-step simultaneous detection of Mycobacterium tuberculosis multidrug-resistant genes using nanoCoTPyP and double quantum dots","volume":"94","author":"Hu","year":"2022","journal-title":"Anal Chem"},{"key":"10.1016\/j.tube.2024.102522_bib121","article-title":"Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system","volume":"27","author":"Colman","year":"2022","journal-title":"J Clin Tuberculosis Other Mycobacterial Dis"},{"key":"10.1016\/j.tube.2024.102522_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228312","article-title":"A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant Mycobacterium tuberculosis in clinical sputum samples","volume":"15","author":"Ou","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib123","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fmicb.2015.00791","article-title":"MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis","volume":"6","author":"Singhal","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib124","article-title":"A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: applications of MassARRAY DNA mass spectrometry","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102209","article-title":"Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients","volume":"135","author":"Shi","year":"2022","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2024.102522_bib126","first-page":"47","article-title":"Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS","volume":"121","author":"Wu","year":"2022","journal-title":"Int J Infect Dis : IJID : Off Publication International Soc Infectious Dis"},{"key":"10.1016\/j.tube.2024.102522_bib127","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/j.csbj.2022.09.031","article-title":"Machine learning analysis of SERS fingerprinting for the rapid determination of Mycobacterium tuberculosis infection and drug resistance","volume":"20","author":"Wang","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.tube.2024.102522_bib128","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01796-2020","article-title":"Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB","volume":"57","author":"Feuerriegel","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102522_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101915","article-title":"Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing","volume":"121","author":"Soundararajan","year":"2020","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2024.102522_bib130","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02605-22","article-title":"Development and assessment of a novel whole-gene-based targeted next-generation sequencing assay for detecting the susceptibility of Mycobacterium tuberculosis to 14 drugs","volume":"10","author":"Wu","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"24","key":"10.1016\/j.tube.2024.102522_bib131","first-page":"1216","article-title":"Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe","volume":"S1198\u2013743X","author":"G\u00fcnther","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2024.102522_bib132","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00641-2021","article-title":"Impact of the revised definition of extensively drug-resistant tuberculosis","volume":"58","author":"Veziris","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102522_bib133","article-title":"Drug resistant TB - latest developments in epidemiology, diagnostics and management","author":"Tiberi","year":"2022","journal-title":"Int J Infect Dis : IJID : Off Publication International Soc Infectious Dis"},{"key":"10.1016\/j.tube.2024.102522_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.09.014","article-title":"Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Microbiol Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.tube.2024.102522_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac042","article-title":"Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania","volume":"4","author":"Mbelele","year":"2022","journal-title":"JAC-Antimicrobial Resistance"},{"key":"10.1016\/j.tube.2024.102522_bib136","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S095026882100279X","article-title":"Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance","volume":"150","author":"Wang","year":"2022","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tube.2024.102522_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.956171","article-title":"Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China","volume":"10","author":"Che","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.tube.2024.102522_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271508","article-title":"Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia","volume":"17","author":"Mesfin","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102522_bib139","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/jmm.0.001221","article-title":"Whole-genome sequencing analysis of multidrug-resistant Mycobacterium tuberculosis from Java, Indonesia","volume":"69","author":"Tania","year":"2020","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tube.2024.102522_bib140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02550-19","article-title":"Systematic review of whole-genome sequencing data to predict phenotypic drug resistance and susceptibility in Swedish Mycobacterium tuberculosis isolates, 2016 to 2018","volume":"64","author":"Enkirch","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102522_bib141","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2147\/IDR.S260161","article-title":"Pyrazinamide resistance and mutation patterns among multidrug-resistant Mycobacterium tuberculosis from Henan Province","volume":"13","author":"Shi","year":"2020","journal-title":"Infect Drug Resist"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:05:18Z","timestamp":1725793518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979224000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":141,"alternative-id":["S1472979224000489"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2024.102522","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2024.102522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102522"}}